Chengdu Kanghong

Chengdu Kanghong is a company listed under the stock ticker 002773 (CN).

View the org chart displaying its 3 main executives

Most searched biographies at Chengdu Kanghong

• Xiao Ke, President and Director
• Zun Hong Ke, Chairman of the Board
• Jian Jun Zhong, Chief Financial Officer

Create your alert
to follow the executive moves at Chengdu Kanghong.

Chengdu Kanghong has 1,859 competitors including Pfizer (United States (USA)), Johnson & Johnson (United States (USA)) and Sanofi (France).

Popular M&A news in Pharmaceuticals

• MedMen has filed for bankruptcy protection  (posted on April 28 2024).
• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Danilo Cicmil - Supervisory Board Member at Galenika
• Emma Walmsley - Chief Executive Officer and Director at GSK

Learn more about the Pharmaceuticals industry >

Press releases by Chengdu Kanghong

Social media about Chengdu Kanghong

• Chengdu Kanghong on Wikipedia, Google News & Yahoo Finance
• Chengdu Kanghong on LinkedIn, Twitter & YouTube

Contact by email its executives including Zun Hong Ke

Call Chengdu Kanghong at +86 288...

View the org chart

Register to receive your alert

Report an error